Asif Ali, Chief Financial Officer at Protagonist Therapeutics, sold PTGX on Sep 30, 2026
Data as of Oct 16
▼ SELL$1.8M12,595 shares at $141.77Asif Ali Chief Financial OfficerPTGX Protagonist Therapeutics, Inc
- Traded
- Sep 30, 2026
- Disclosed
- Oct 2, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
PTGX since disclosure
−8.1%
after the sale
Similar stocks (XLV) since disclosure
+6.3%
XLV — its sector index fund
Change in closing price from Oct 2, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLAsif Ali Chief Financial OfficerPTGX Protagonist Therapeutics, Inc$6.5Mdisclosed Oct 2 · filed 2 days after the trade